Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.07. | Chugai and Gero link on antibody drugs for age-related conditions | 5 | Pharmaceutical Technology | ||
26.06. | Roche-Tochter Chugai beantragt Zulassungserweiterung für Krebsmittel Alecensa | 35 | cash | ||
CHUGAI PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
19.06. | NEC Corporation: NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment | 424 | JCN Newswire | - Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% -TOKYO, June 18, 2025 - (JCN Newswire) - NEC Corporation (NEC; TSE: 6701), in collaboration... ► Artikel lesen | |
19.05. | Rani Therapeutics erforscht orale Verabreichung von Chugai-Medikamenten | 10 | Investing.com Deutsch | ||
19.05. | Rani Therapeutics explores oral delivery of Chugai's drugs | 4 | Investing.com | ||
19.05. | Rani Therapeutics Announces Research Agreement with Chugai | 331 | GlobeNewswire (Europe) | - Research agreement is evaluating feasibility of applying Rani's oral delivery technology to Chugai's antibodies against undisclosed targets - SAN JOSE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Rani... ► Artikel lesen | |
18.04. | Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai | 16 | Japan Times | ||
30.07.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.07.2024 | 972 | Xetra Newsboard | The following instruments on XETRA do have their first trading 30.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.07.2024
Aktien
1 US1712691039 Chugai Pharmaceutical... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TRULIEVE CANNABIS | 3,606 | +3,56 % | Trulieve Cannabis Corp.: Trulieve Reports First Quarter 2025 Results Demonstrating Core Business Strength | First quarter revenue of $298 million, with 62% gross margin
Cash flow from operations of $51 million and free cash flow of $34 million *
4/20 holiday season... ► Artikel lesen | |
WEST PHARMACEUTICAL SERVICES | 180,00 | -0,83 % | West Pharmaceutical Appoints Robert McMahon As CFO | WASHINGTON (dpa-AFX) - West Pharmaceutical Services, Inc. (WST), Monday announced the appointment of Robert McMahon as the company's Chief Financial Officer, effective August 4, 2025.McMahon... ► Artikel lesen | |
SHIONOGI | 14,500 | +0,69 % | Adhoc: BioVersys AG: BioVersys And Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate | BioVersys AG / Key word(s): Agreement/Partnership
BIOVERSYS AND SHIONOGI ENTER INTO GLOBAL RESEARCH COLLABORATION FOR BROAD-SPECTRUM NON-TUBERCULOUS MYCOBACTERIA (NTM) CLINICAL... ► Artikel lesen | |
KALA BIO | 4,860 | -2,25 % | KALA BIO, Inc.: KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) | -- Topline results from the CHASE trial expected by end of Q3 2025 -- -- Potential for CHASE to serve as a pivotal trial in support of a Biologics License Application (BLA) submission, contingent... ► Artikel lesen | |
CHARLOTTES WEB | 0,080 | 0,00 % | Charlotte's Web: 750.000-Dollar-Darlehen für Joint Venture DeFloria | ||
BEXIMCO PHARMACEUTICALS | 0,428 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 03.07.2025 | The following instruments on XETRA do have their last trading day on 03.07.2025Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 03.07.2025ISIN NameAU3CB0222354 FMO-N.FIN.-M.O. 2025... ► Artikel lesen | |
LUYE PHARMA | 0,400 | -1,96 % | LUYE PHARMA (02186): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2025 | ||
GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc. - 15-12G, Securities registration termination | ||
PERCHERON THERAPEUTICS | 0,007 | +40,00 % | XFRA AWY0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
MIRUM PHARMACEUTICALS | 46,800 | +4,46 % | Mirum Gains 35% in 3 Months: How Should You Play the Stock? | ||
AYURCANN | 0,009 | 0,00 % | Ayurcann Holdings Corp.: Ayurcann Reports Another Record Sales Growth In Q2 2025 Of $13,363,509 | Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company") is excited to announce record-breaking financial results for the... ► Artikel lesen | |
AVANT BRANDS | 0,432 | 0,00 % | Avant Brands Inc.: Avant Brands Announces Results for Q2 2025 | KELOWNA, BC / ACCESS Newswire / July 15, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products,... ► Artikel lesen | |
EVEREST MEDICINES | 7,950 | 0,00 % | Everest Medicines Limited: Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation | HONG KONG, July 4, 2025 - (ACN Newswire) - Everest Medicines (HKEX: 1952.HK) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held in Shanghai.... ► Artikel lesen | |
KALBE FARMA | 0,072 | -0,69 % | KLBF subsidiary partners with GE HealthCare to produce local CT scans: KLBF inaugurates new factory ... | ||
KOBAYASHI PHARMACEUTICAL | 29,000 | 0,00 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen |